| HOME >> MEDICINE >> TECHNOLOGY |
SALEM, N.H., Oct. 9 /PRNewswire/ -- The Wellion Linus Blood Glucose Monitoring System, powered by WaveSense technology for high accuracy testing, recently received certification by the Netherlands Organization for Applied Scientific Research TNO ("TNO"). TNO is an independent group founded in 1932 that thoroughly tests and inspects medical devices. The Wellion Linus Blood Glucose also carries the CE Marking.
"Receiving the TNO approval is a testament to the quality and accuracy of WaveSense products," said Dr. E. van Ballegooie, one of the leading physicians in the Belgium/Netherlands/Luxembourg region. "Roche and Abbott are the other major brands to receive the TNO approval; this clearly demonstrates that WaveSense is one of the leading technologies in the world."
In addition to market leading features such as having a fast test time, small sample size, and large backlit display, the Wellion Linus's main feature is its ability to provide high accuracy test results due to its WaveSense technology. For a list of the other blood glucose monitors that have received TNO approval, see: http://www.tnokeur.nl/.
"TNO is known throughout Europe for their high standards and its tests are often more rigorous than the requirements for the mandatory CE Marking. We are honored to place the prestigious TNO seal on our WaveSense products. TNO certification is a tremendous advantage since we are penetrating demanding markets, such as The Netherlands, where users prefer very rigorous accuracy standards for home blood glucose monitoring systems," said Werner Trenker, CEO of MedTrust, distributor of WaveSense products in Europe.
WaveSense technology is a suite of patented technologies that enable
high accuracy glucose monitoring products. WaveSense employs Dynamic
Electrochemistry to extract a spectrum of information inaccessible to
traditional static electrochemistry methods. WaveSense technology aids in
'/>"/>
| SOURCE AgaMatrix Copyright©2007 PR Newswire. All rights reserved |